Nuclear Medicine and Neurooncology (NMN)

#Agenda

@nmnsymposium.bsky.social

🤩 💫 We are delighted to announce that the registration & abstract submission for the NMN Symposium 2026 to be held in Vienna from May 07-08th 2026 is open now!

Program: www.nmn-society.org/program/
Abstract submission: www.nmn-society.org/abstracts/
Registration: www.nmn-society.org/registration/

🧠 Thank you for joining us at the recent #EANOYoungsters Journal Club session: Lighting up PET imaging in IDH mutant gliomas
👉 Missed the latest session? No worries – you can catch up by watching the recording on YouTube: youtu.be/0i9XVEjDs5c?...

We look forward to seeing you at our next session!

Back to cold Vienna 🥶 after #SNO2025 #WFNOS2025 in Honolulu! 🌺🏝️
Great talks, inspiring discussions, presenting own data, catching up with friends & colleagues - all made even better by Hawaiian sunshine. 😎
Last conference of 2025 in the books. Looking forward to what’s next in 2026! 🚀 #btsm

That’s a wrap on WFNOS/SNO 2025 in Honolulu, Hawaii!
The #EANO team truly enjoyed connecting with colleagues from around the world, exchanging insights, and celebrating SNO’s 30th anniversary. A big thank you to the @neuroonc.bsky.social for hosting this inspiring meeting! 🌺

#SNO2025 #WFNOS2025

Mechanisms and treatment of cancer therapy-induced peripheral and central neurotoxicity - Nature Reviews Cancer Neurotoxicity impacting the central and peripheral nervous systems is a considerable adverse effect of both conventional and novel cancer therapies. In this Review, Karschnia et al. outline what is currently known about the mechanisms that underlie the clinical symptoms of central nervous system injury and peripheral neuropathy and the ongoing development of interventions to treat and prevent this unmet medical need.

ICYMI 🚨

Neurotoxicity impacting the central & peripheral nervous systems is an adverse effect of cancer therapies. In this #Review, Karschnia et al. outline the mechanisms that underlie the clinical symptoms & the need for interventions to treat it.

👇

Awarded as best clinical science poster at #EANO2025 and now published online: "Clinical potential of [18F]FET PET in patients with circumscribed astrocytic glioma" by @jmwerner.bsky.social and colleagues.
👉 link.springer.com/article/10.1...
#NuclearMedicine #Glioma #NeuroOncology #PETImaging

Outstanding oral presentation at #EANO2025 in Prague, now published in #NeuroOncology: the Multicenter Randomized Phase II Study of R-MPV-A #Chemoimmunotherapy With or Without Low-Dose Whole-Brain #Radiotherapy for Newly-Diagnosed Primary... by Antonio Omuro & colleagues.
👉 doi.org/10.1093/neuo...

🧠 Thank you for joining us! The #EANOYoungsters #JournalClub on “Lighting up PET imaging in IDH mutant gliomas” brought together colleagues worldwide for a vibrant exchange on cutting-edge #NeuroOncology research.
▶️ Missed it? The recording will be available soon:
www.youtube.com/@eano_associ...

✏️Our Editorial - International funding for cancer care: a shared responsibility

thelancet.com/journals/lan...

🎧Listen to our podcast: Deputy Editor Ali Landman speaks with Matthias Preusser on the phase 2 TUXEDO-3 trial in patients with brain metastases

thelancet.com/multimedia/p...

🎧 Check out the The Lancet Oncology podcast discussing the back-to-back publications of the TUXEDO-3 trial: www.thelancet.com/doi/story/10...

👉 Cohort 1 (breast cancer) paper:
authors.elsevier.com/a/1m007_XRRT...

👉Cohort 2 (lung cancer) paper: authors.elsevier.com/a/1m0075EIIg...

Two studies led by former #EANO President Matthias Preusser demonstrate the activity of HER3-DXd in patients with brain metastases from breast and lung cancer.
Just published back-to-back in @thelancetoncol.bsky.social:
👉 breast cancer: bit.ly/4oEN1T2
👉 lung cancer: bit.ly/3LarqUf
#TUXEDO3

🔥 The program for #NMN2026 is online: www.nmn-society.org/program/! Check out the outstanding speaker panel and cutting edge topics on PET imaging and theranostics of primary and secondary CNS tumors.

☢️ Insightful perspective article by William Chen and David Raleigh on the LUMEN-1 trial in The Journal of Nuclear Medicine :
jnm.snmjournals.org/content/earl...
@eortc.org

🔥 Check out the brand new editorial featuring the two randomized sister trials from Europe and the US on theranostics for meningioma in the Journal of Nuclear Medicine: jnm.snmjournals.org/content/earl...
@eortc.org

🧠 💫 Amino acid PET imaging and its potential role for supramarginal resection being discussed at #EANO2025.
@eanoassociation.bsky.social

🤩 Emeline Tabouret presenting the randomized phase II LUMEN-1 (EORTC-2334-BTG) trial on Lu-DOTATATE in recurrent meningioma at #EANO2025 - 🚀 accrual going very well!
@eortc.org @eanoassociation.bsky.social

🌍 Strengthening medical imaging capacity will save lives: spotlight on the recent @who.int landmark resolution on strengthening medical imaging capacity worldwide.
www.nature.com/articles/s41...
@natureportfolio.nature.com

🤩 🤝 Looking forward to welcoming the Editor-in-Chief of The Lancet Oncology David Collingridge at #NMN2026: www.nmn-society.org!
@thelancetoncol.bsky.social
www.thelancet.com/journals/lan...

🤩 Proud to announce that COGNO is endorsing the #NMN2026 Symposium to be held on May 07/08th 2026 in Vienna: www.nmn-society.org! 🌍 Looking forward to collaborating with our colleagues from Australia on molecular imaging and theranostics for brain tumors! 💫
cogno.org.au
@nathaliealbert.bsky.social

How to disconnect therapy-resistant tumor networks in glioblastoma?

In our paper, online @Cancer Discovery, we built an anti-tumor microtube (TM) screening pipeline and found that Protein Kinase C activators disrupt TMs, silence Ca²⁺ “pacemakers” and boost radiotherapy.
doi.org/10.1158/2159...

💫 New publication in EJNMMI: "Revealing the hidden: A systematic review and meta-analysis of FAPI-based tracers imaging for brain metastatic lesions."
link.springer.com/article/10.1...

💫 Check out the new article in the inaugural issue of the new EANM Journal:
EANM insights on PET-based response assessment in neuro-oncology: things are moving forward!
doi.org/10.1016/j.ea...
@eanm.org

We’re thrilled to see so many high-quality submissions coming in for our journals! 🎉

Explore the latest publications and the editorials written by our EANM Board and Editors-in-Chief:

👉 The EANM Journal: sciencedirect.com/journal/the-...
👉 EANM Innovation: sciencedirect.com/journal/eanm...

[177Lu]Lu-DOTATATE for refractory meningiomas: factors associated with the therapeutic response and initial tumor dosimetric data - European Journal of Nuclear Medicine and Molecular Imaging Purpose This study aimed to reveal the factors affecting the therapeutic response of refractory meningiomas treated with [177Lu]Lu-DOTATATE and to collect initial tumor absorbed doses. Methods Patient...

🚨New paper in EJNMMI: [177Lu]Lu-DOTATATE for refractory meningiomas: factors associated with the therapeutic response and initial tumor dosimetric data.
link.springer.com/article/10.1...

Who’s ready for 2025 WFNOS/SNO Annual meeting in Honolulu?!

Register by Sept 19 to get early bird pricing and join colleagues from around the world in advancing #neurooncology.

soc-neuro-onc.org/SNO2025

EANS-EANO Guidelines on the extent of resection in gliomas Abstract. Intense efforts are employed to optimize neurosurgical resection of gliomas in different clinical scenarios. However, the level of evidence emplo

🧠 EANS-EANO Guidelines on the extent of resection in gliomas.
academic.oup.com/neuro-oncolo...

@eanoassociation.bsky.social @neuroonc.bsky.social

🚨 💫 Happy to share that that @eortc.org is a 🙌 collaboration partner for the #NMN2026 Symposium: www.nmn-society.org!
@nathaliealbert.bsky.social

🚨 New publication in Journal of Nuclear Medicine: Retrospective Evaluation of the Correlation Between Somatostatin Receptor PET/CT and Histopathology in Patients with Suspected Intracranial Meningiomas.
jnm.snmjournals.org/content/earl...

Implementation of Radiotheranostics: Challenges, Barriers, and IAEA-Driven Strategies for Sustainable Access Radiotheranostics represent a cutting-edge advancement in the management of noncommunicable diseases, integrating diagnostic imaging with targeted rad…

🌎 ☢️ 🩺 Implementation of Radiotheranostics: Challenges, Barriers, and IAEA-Driven Strategies for Sustainable Access.
www.sciencedirect.com/science/arti...